# Evaluation of the Efficacy and Safety of Subcutaneous Ketamine in the Treatment of Depressive Episode With Suicidal Ideation and/or Behavior in Adolescents

> **NCT06957704** · PHASE3 · NOT_YET_RECRUITING · sponsor: **Federal University of São Paulo** · enrollment: 60 (estimated)

## Conditions studied

- Depressive Disorder
- Suicidal Ideas

## Interventions

- **DRUG:** ketamine
- **DRUG:** Midazolam

## Key facts

- **NCT ID:** NCT06957704
- **Lead sponsor:** Federal University of São Paulo
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-05
- **Primary completion:** 2028-04
- **Final completion:** 2028-04
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2025-05-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06957704

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06957704, "Evaluation of the Efficacy and Safety of Subcutaneous Ketamine in the Treatment of Depressive Episode With Suicidal Ideation and/or Behavior in Adolescents". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06957704. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*